Category:Antineoplastic drugs
 | This category reflects the organization of Anatomical Therapeutic Chemical Classification System code L01. Generally, drugs outlined within the ATC code L01 should be included in this category. Please see WP:PHARM:CAT for more information. |
Wikimedia Commons has media related to Antineoplastic agents.
Subcategories
This category has the following 17 subcategories, out of 17 total.
A
- Antibody-drug conjugates (58 P)
B
C
D
E
- Experimental cancer drugs (262 P)
H
M
- Mitotic inhibitors (32 P)
- Monoclonal antibodies for tumors (141 P)
P
- Photosensitizing agents (8 P)
- Proteasome inhibitors (10 P)
T
Pages in category "Antineoplastic drugs"
The following 200 pages are in this category, out of approximately 220 total. This list may not reflect recent changes.
(previous page) (next page)A
- Abexinostat
- Acalabrutinib
- Aceglatone
- Acutissimin A
- Adagrasib
- Afatinib
- Alestramustine
- Alitretinoin
- AM-251 (drug)
- Aminolevulinic acid
- Amphinex
- Amsacrine
- Anagrelide
- Angiozyme
- Anthramycin
- Antibody–drug conjugate
- Anticarcinogen
- List of antineoplastic agents
- Apaziquone
- Arsenic trioxide
- Asandeutertinib
- Asparaginase
- Asunercept
- Ateganosine
- Atrimustine
- Axicabtagene ciloleucel
- Azaserine
C
- Cabozantinib
- Calaspargase pegol
- Camizestrant
- Camonsertib
- Canakinumab
- Capmatinib
- Celecoxib
- Cell-cycle nonspecific antineoplastic agents
- Chemically linked Fab
- Chemoimmunotherapy
- Chemoprotective agent
- Chemosensitizer
- Chemotherapy
- Chemotherapy-induced nausea and vomiting
- Ciltacabtagene autoleucel
- Copanlisib
- Crelosidenib
- Cytestrol acetate